ANG Lifesciences India Limited

₹38.44As of Sun 8 Nov 2026, 12:00 UTC
BSE:540694Healthcare
Country India
PE (Fwd) •••
TSR 9Y CAGR 0.73%
Div yield —
ROE (18.97%)
Pharmaceutical Preparations
Beta (5Y) 0.78
PE TTM —
TSR TTM 23.92%
Mkt cap ₹502.0M
ROIC (5.94%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹45
17.59%
(78.67%)
Hold 8|5|1|9|11
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.45
0.45
0.43
0.48
21.24%
7.90%
(4.05%)
1.08%
Revenue₹M
21.02
21.60
22.23
23.14
0.25%
5.53%
3.62%
8.66%
Peers (US$5.292M)
Cap (US$)
PE
5.961M
3.176x
5.781M
1.877x
Capital
TTM
5Y
10Y
Leveragex
0.204
0.049
0.042
EBIT/Intx
0.911
0.451
0.409
Own earn%
16.16
96.54
94.67
Sh yield%
18.81
25.96
27.27
Owners
Insiders/Inst%
7.92
75.70
Short interest%
2.76
SBC / revenue%
5.73
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
21–27
$1 testx
0.0
Incr. ROIC%
7